or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    AGEN C Agenus Inc. -6.56
    NXTC D NextCure, Inc. 0.18
    CCCC D C4 Therapeutics, Inc. 2.09
    ADAP D Adaptimmune Therapeutics plc -2.78
    EVAX D Evaxion Biotech A/S 0.26
    CNTA D Centessa Pharmaceuticals plc -0.22
    PYXS D Pyxis Oncology, Inc. 1.39
    PBYI D Puma Biotechnology Inc 1.73
    NVCR D NovoCure Limited -1.03
    GMAB F Genmab A/S 0.83
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Medicine Small Cell Lung Cancer Biotechnology Immunotherapy Solid Tumors Melanoma Biopharmaceutical Cancer Treatment Immunotherapies Multiple Myeloma Ovarian Cancer Acute Myeloid Leukemia Advanced Cancer Antibody Drug Conjugate Cancer Immunotherapy Cancer Vaccine Drugs Epidermal Growth Factor Receptor

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.62
    CNCR D Loncar Cancer Immunotherapy ETF 2.17
    FDM A First Trust DJ Select MicroCap ETF 1.51
    FORH A Formidable ETF 1.34
    XBI D SPDR S&P Biotech ETF 0.98
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare BBC to FDM Compare CNCR to XBI Compare FDM to XBI

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        May 7 EVAX Sidoti Events, LLC's Virtual May Micro-Cap Conference
        May 7 AGEN Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
        May 7 AGEN Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments
        May 7 AGEN Agenus GAAP EPS of -$3.04 beats by $0.18, revenue of $28M misses by $19.17M
        May 7 AGEN Agenus Reports First Quarter 2024 Results
        May 7 AGEN Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
        May 6 AGEN Agenus Q1 2024 Earnings Preview
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 NVCR NovoCure Limited Q1 Earnings: Core Business Accelerating
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 GMAB Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
        May 3 NVCR NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 NVCR NovoCure (NVCR) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Small Cell Lung Cancer Solid Tumors Medicine Melanoma Cancer Immunotherapy Drugs Lung Cancer Multiple Myeloma NSCLC Acute Myeloid Leukemia Antineoplastic Drugs Breast Cancer Cancer Treatment Carcinoma Hematological Malignancies Immunotherapy Non Small Cell Lung Carcinoma
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags